What is the clinical description of hand eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Clinical Description of Hand Eczema

Hand eczema is a heterogeneous inflammatory skin disease affecting the hands and wrists, characterized by erythema, scaling, pruritus, pain, burning sensation, and often fissuring, with variable clinical presentations that can be acute or chronic, affecting palmar and dorsal surfaces, fingers, fingertips, and wrists. 1, 2

Clinical Presentation

Hand eczema manifests with diverse morphological patterns that vary in severity and appearance over time. The most commonly affected anatomical sites include:

  • Palms (56.6% of patients)
  • Fingertips (41.6%)
  • Backs of hands (40.8%) 3

Primary Clinical Features

The cardinal signs and symptoms include:

  • Erythema (most frequent sign)
  • Pruritus (most frequent symptom)
  • Scaling
  • Fissuring
  • Pain and burning sensation
  • Induration (in chronic hyperkeratotic forms) 4, 1, 3

Clinical Subtypes by Morphology

The clinical presentation varies significantly based on the subtype. Chronic hyperkeratotic hand eczema presents with induration, scaling, and fissuring, while pompholyx (dyshidrotic eczema) presents differently with vesicular eruptions 4. This morphological heterogeneity is why simplified assessment tools measuring only three variables (induration, scaling, fissuring) are useful only for certain types like chronic hyperkeratotic hand eczema but inadequate for others 4.

Etiological Classification

Hand eczema is classified based on suspected main causes:

  • Irritant contact dermatitis (40.1% of moderate-to-severe cases)
  • Atopic hand eczema (33.1%)
  • Allergic contact dermatitis (27.5%) 3

A critical clinical caveat: The pattern and morphology of hand dermatitis is unreliable in predicting cause and distinguishing atopic/endogenous dermatitis from contact irritant or contact allergic etiology 4. This means you cannot diagnose the subtype based on appearance alone—detailed history and patch testing are essential.

Chronicity Definition

Hand eczema is defined as chronic when it persists for more than 3 months or recurs at least twice within one year 5, 6. Up to two-thirds of affected individuals develop chronic disease with substantial personal and occupational disability 1.

Key Historical Features to Elicit

The British Association of Dermatologists guidelines 4 specify essential historical points:

  1. Atopic history: Personal history of childhood atopic dermatitis, asthma, hay fever, or family history of atopy (43.8% of moderate-to-severe CHE patients have history of atopic dermatitis) 3

  2. Distribution pattern: Where symptoms began and how they spread

  3. Product exposure: Cosmetics, personal-care products, topical medications, clothing, bandages, gloves

  4. Wash products: Detailed history of all products contacting skin, as most contain harsh emulsifiers/surfactants causing barrier damage in predisposed individuals 4

  5. Activity-related triggers: Hairdressing, holidays, home improvements, painting, decorating, recreation, sport

  6. Occupational factors: Detailed workplace history, products handled, health and safety data sheets review

  7. Environmental variation: Improvement during weekends/holidays with recurrence on return to work suggests occupational etiology

  8. Photosensitivity: Worsening after sunlight exposure

  9. Irritant exposure: Both wet agents (water, frequency of hand washing) and dry, desiccating products 4

Clinical Assessment

Use standardized clinical assessment tools for both initial evaluation and treatment response monitoring 4:

  • Hand Eczema Severity Index (HESI) - comprehensive objective scoring
  • Dermatology Life Quality Index (DLQI) - generic quality of life measure
  • Investigators Global Assessment (IGA) - simplified tool measuring induration, scaling, fissuring (quick but only valid for chronic hyperkeratotic type, not pompholyx) 4

Important Clinical Pitfall

Many patients with moderate-to-severe chronic hand eczema have no atopic condition besides CHE and no history of atopic dermatitis, indicating that CHE is not simply atopic dermatitis of the hands 3. This challenges the assumption that hand eczema in adults is primarily an extension of atopic disease and underscores the importance of considering irritant and allergic contact dermatitis even in the absence of atopic history.

References

1
Research

Hand eczema.

Lancet (London, England), 2024

2
Research

Hand Eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-up.

Journal of the American Academy of Dermatology, 2024

5
Research

Chronic Hand Eczema (CHE): A Narrative Review.

Dermatology and therapy, 2025

Related Questions

How can I differentiate eczema from scabies on the hands?
What is the appropriate management for severe hand eczema in a 10‑year‑old child?
What is the best treatment for eczema presenting with hyperpigmented, pruritic lesions over the right hand finger joint in a 25-year-old male?
What is the recommended treatment for hand eczema in an adult?
What is the appropriate management for erythema and burning sensation on the hand?
Which oral acute antihypertensive can be used safely in a patient with chronic kidney disease?
How should I evaluate and manage a patient who presents with emotional bluntness?
What amount (in mL) of infant‑strength acetaminophen (Tylenol) 160 mg per 5 mL should be given to a 4‑month‑old infant weighing 13 lb?
What is the appropriate dose of MiraLAX (polyethylene glycol 3350) for a 2‑year‑old child weighing approximately 12–14 kg?
How should abdominal adhesions seen on imaging be managed in asymptomatic patients and in those presenting with signs of bowel obstruction?
When initiating chronic suppressive therapy with fosfomycin, is a negative urinalysis and urine culture with sensitivity required before starting treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.